CMS, FDA unveil speedier Medicare coverage pathway for breakthrough devices
Summary
The pathway is designed to reduce the delay between FDA authorization and Medicare coverage for certain Class II and Class III breakthrough medical devices.
Description
The pathway is designed to reduce the delay between FDA authorization and Medicare coverage for certain Class II and Class III breakthrough medical devices.
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source